-
Proteon Therapeutics Inc (NASDAQ: PRTO) tumbled
74.3 percent to $2.55 after the company disclosed that it did not meet primary endpoint in PATENCY-1 trial.
-
Inovalon Holdings Inc (NASDAQ: INOV) dropped 35.6
percent to $9.60 as the company cut its earnings and revenue guidance for full year 2016.
-
Apricus Biosciences Inc (NASDAQ: APRI) shares
fell 23.5 percent to $1.37. Apricus Biosciences shares have jumped 110.59 percent over the past 52 weeks, while the S&P 500
index has gained 11.62 percent in the same period.
-
aTyr Pharma Inc (NASDAQ: LIFE) shares dipped 20.6
percent to $2.90 after the company disclosed clinical results from exploratory trials with Resolaris.
-
LifeVantage Corp (NASDAQ: LFVN) shares fell 15.5
percent to $8.19. LifeVantage reported Q1 earnings of $0.13 per share on revenue of $54.9 million.
-
Anavex Life Sciences Corp. (NASDAQ: AVXL) shares
dropped 13.2 percent to $4.23. Anavex Life Sciences shares have dropped 35.87 percent over the past 52 weeks, while the S&P
500 index has gained 11.62 percent in the same period.
-
Endologix, Inc. (NASDAQ: ELGX) shares declined
9.4 percent to $6.24 as the company disclosed that it has received suspension of CE Mark for AFX System.
-
Globus Maritime Ltd (NASDAQ: GLBS) shares fell
7.4 percent to $5.81 after climbing 5.03 percent on Monday.
-
National Storage Affiliates Trust (NYSE: NSA) fell
6.6 percent to $20.80. National Storage Affiliates Trust prices its public offering of 4.5 million common shares for gross
proceeds of around $94.5 million.
-
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) dropped 6.3 percent to $1.88 after the company disclosed that its
Clonidine Topical Gel Phase 2b trial missed the primary endpoint.
-
Arbutus Biopharma Corp (NASDAQ: ABUS) slipped 5.1
percent to $ 2.80 after the company issued additional data from its ARB-1467 Phase II trial in HBV patients. Chardan Capital
downgraded Arbutus Biopharma from Buy to Neutral and lowered the price target from $4.00 to $3.00.
-
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) fell
3.5 percent to $111.09. Morgan Stanley downgraded Alexion Pharmaceuticals from Overweight to Equal-Weight.
-
Hancock Holding Company (NASDAQ: HBHC) shares
declined 3 percent to $42.70. Hancock Holding disclosed a 5 million share common stock offering.
-
Buffalo Wild Wings (NASDAQ: BWLD) slipped 2.5
percent to $170.02. BMO Capital downgraded Buffalo Wild Wings from Outperform to Market Perform.
-
Littelfuse, Inc. (NASDAQ: LFUS) dropped 2.2
percent to $152.08. Longbow Research downgraded Littelfuse from Buy to Neutral.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.